2-Tolualdehyde, 98.0%, 25g

Moexipril hydrochloride, 98%, 100mg

1-{4-[(4-chloro-1{H}-pyrazol-1-yl)methyl]phenyl}methanamine, 2g

3,5-Dimethyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-pyrazole, 95.0%, 1g

3-Bromo-1-(pyridin-2-yl)pyridin-2(1H)-one, 1g

GC capillary column ROTI®Cap-1, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)

2-Ethynyl-3-fluorobenzaldehyde, 5g

5-Chloro-2,2-difluoro-benzo[1,3]dioxole, 95.0%, 5g

4-Fluoro-L-phenylalanine ethyl ester hydrochloride, 98.0%, 1g

Sodium 2-bromoethanesulfonate, 95.0%, 100g

Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3-iodo-4-methoxyphenyl)propanoate, 95+%, 100mg

2-Oxa-6-azaspiro[3.3]heptane oxalate, 95.0%, 25g

2-Methoxyisophthalic acid, 97.0%, 5g